GSK-933776 | Interleukin Related interleukin-related.com

Product Name :
GSK-933776

Search keywords :
GSK-933776

drugId :
null

Target Vo:
Beta amyloid A4 protein

Target Vo Short Name :
APP

Moa_Name:
Beta amyloid A4 protein inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Alzheimer Disease

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Farletuzumab Anti-infection
c-Jun Rabbit mAb Epigenetic Reader Domain
CDX2 Antibody: CDX2 Antibody is an unconjugated, approximately 34 kDa, rabbit-derived, anti-CDX2 monoclonal antibody. CDX2 Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human, mouse, rat background without labeling.

Author: Interleukin Related

Related Posts